Company Press Release
Source: ;MedCare Technologies Inc.
MedCare Plans To Offer Non-Drug, Non-Surgical Treatment Program To The Nursing Home Market Where Half Of All Residents suffer From Urinary Incontinence.
In Addition To 4 Operating Centers In OK, KS, FL And CO, MdCare Plans To Establish 8 additional Incontinence Treatment Sites In 1997/b
LISLE, Ill., June 2/PRNewswire/ -- MedCare Technologies, Inc. (Nascaq: MCAR - news) today announced plans to offer The NedCare Program, a non-surgical, non-drug and non-invasive treatment program for urinary incontinence, to the multi-billion dollars nursing home market. According to the US Department of Health, urinary incontinence (UI) is one of the major reasons why Americans institutionalize elderly family members, accounting for upwards of 50% of all admissions into nursing homes. At present, an estimated 40% to 60% of all nursing home residents suffer from UI, representing over 1.5 million individuals who are ordinarily resigned to using absorbent products or containment devices while in these facilities. In order to make available The MedCare Program to this marketplace, MedCare Technologies plans to expand the scope of its program to include specially trained clinicians to exclusively serve the nursing home patient. MedCare plans to initially add the nursing home component to select existing and future MedCare centers.
In addition to the company's presently operating and recently opened MedCare Program sites in Norman, OK, Overland Park, KS, Winter Park, FL and Denver, CO, MedCare Technologies plans to open an additional 8 centers during the balance of 1997, bringing the total to 12 centers by year end. As the Company expands its clinical netword, MedCare plans to hire additional senior managerial and sales and marketing executives in the near future.
Urinary Incontinence is a 16 Billion Market and Affects Almost Half of All Women.
Numerous studies have been completed to determine the prevalence of urinary incontinence in the general polulation. The results of one study completed at Emory University in Atlanta, GA, concluded that the Prevalence of UI was 43.6% among women and 20.9% among men. In another study of 3,638 patents over age 20, 1908 women and 922 men completed an anonymous questionnaire. A reported 43% of women and 11% of men had current UI. almost 75% of these patents had not informed a health professional, but more than a thrid of these said they would see a physician if treatment were available. Affecting some 25 million Americans, Ui is a $16 billion market and accounts for almost half of all nursing home admissions. Despite being one of the most prevalent medical conditions in health care today, with almost half of all women being affected at some point, Ui remains a vastly underserviced and overlooked market place.
The MedCare Program Does Not Require FDA Approval and is Risk Free.
MedCare Thchnologuies has developed a cost effective, non-drug, non-surgical and non-invasive system for the care and treatment of patients suffering from urinary incontinence. MedCare's treatment protocol does not require FDA approval, is covered by most heealth insurance plans and results in the reduction or complete elimination of 70% to 100% of the most commonly found urinary incontinence symptoms. Unlike traditional treatment options, which are costly, often unsuccessful or inadequate, MedCare's proprietary treatment program is completely risk free and has a three year history with a proven success rate in excess of 85%. MedCare Technologies offers a multi-modality program based on behavioral techniques and neuromuscular electromyography biofeedback. The MedCare Program is deisgned to mobilize and strengthen various sensory-response systems and is based on operant conditioning strategies whereby specific physiological responses are progressively shaped, strengthened and coordinated.
_______________________
SOURCE:MedCare Technologies Inc.
Contact: Bill Mann of MedCare Technologies, 800-600-3388
_______________________
More news for referenced ticker symbols: MCAR, and related industries: medical |
